Social prescribing (SP) connects people to community activities and services to address practical, social and emotional needs. Digital platforms are increasingly used to support referral, and case management and data sharing. Artificial intelligence (AI) tools, such as predictive models, recommender systems, natural language processing, and conversational agents, may further support identification, matching, follow-up, and evaluation. However, there is no international overview of how AI and advanced digital tools are currently used in real-world SP initiatives, and what outcomes, equity implications, and implementation issues are reported.To map and categorise AI and digital health applications used in SP internationally, describe contexts and target populations, summarise reported outcomes and implementation considerations, and identify knowledge and methodological gaps.We will conduct a scoping review reported in accordance with PRISMA-ScR. We will include SP initiatives in any country and care setting that uses digital tools across the pathway (case finding, referral, triage, matching, follow-up, monitoring, or evaluation). Eligible sources will include quantitative, qualitative, and mixed-methods studies and implementation/process evaluations published between 2000 and 2025 in English, Portuguese, Spanish, Turkish, or French. We will search MEDLINE, Embase, Web of Science Core Collection, Scopus, and Google Scholar using a predefined strategy combining controlled keywords. Two reviewers will independently screen and extract data, resolving disagreements by consensus or a third reviewer. Tools will be classified as AI-enabled, rule-based, or non-AI digital infrastructure. We will summarise evidence descriptively (country, setting, population, technology type and pathway stage), develop a practical taxonomy and pathway-stage map linking technologies to outcomes (process, wellbeing/clinical, service use, economic and equity-related), and synthesise implementation findings thematically, focusing on barriers, facilitators and ethical issues (privacy, transparency, interoperability, workforce readiness and digital exclusion).The review process is ongoing, and the results will be presented at the congress.This review will clarify current practice and identify where evidence is concentrated or absent, supporting more consistent evaluation and safer adoption.An international map of technology-supported social prescribing will inform primary care teams, link workers, and decision makers on effective and equitable design and implementation.

Subsyndromal depression (SSD) is highly prevalent among older adults yet remains underrecognised and undertreated. Despite evidence that early intervention may prevent progression to syndromal depression, there is a lack of community and primary care services for seniors with SSD, as most mental health services are diagnosis-dependent.This study aims to develop and evaluate a 12-week community-based intervention programme for seniors with SSD, comprising of psychoeducation sessions and social prescription by health companions. We hypothesised that the intervention programme would be aceptable to the seniors with SSD, reducing their feelings of loneliness and anxiety, while increasing their depression literacy and general well-being.This is a mixed-methods study design, combining standardised questionnaires with in-depth interviews to explore participants’ outcomes and experiences. Quantitative measures assessed depression (PHQ-9), anxiety (GAD-7), loneliness (UCLA Loneliness Scale v3), well-being (WHO-5), disability (WHODAS 2.0), depression literacy (D-Lit), and health-related quality of life (EQ-5D-5L), alongside sociodemographic and utilisation data on psychological service. Participants aged 55 years and above with SSD (PHQ-9 score 5–9) were recruited via convenience sampling from polyclinics.Fifteen participants were recruited, of whom nine completed the 12-week intervention, all assessments, and interviews. Pre-post intervention scores showed reductions in median scores in depression (7 to 6), anxiety (4.9 to 4.3), and loneliness (39.8 to 36.2), alongside improvement in health-related quality of life (EQ-5D-5L VAS: 78 to 80). Conversely, median depression literacy decreased (10 to 9) and disability scores increased (5 to 7). Qualitative findings indicated that participants valued small-group, in-person psychoeducation for its human connection, relatability, and practical materials that supported understanding and coping strategies.This pilot study may show positive feedback from the participants and improvement in participants' mood but conclusions are limited by the small sample and high attrition. Unexpected changes in depression literacy and disability suggest the need to refine the programme content. Further research with larger sample is needed to confirm its effectiveness, understand reasons for dropout, and optimise the intervention.Overall, these findings highlight the potential of a community-based intervention for seniors with subsyndromal depression, while underscoring the need for larger, more robust studies to refine the programme and confirm its effectiveness.

Social Prescribing (SP) is an innovative approach to support patients with psychosocial health-related problems through the implementation of a new referral pathway from general practitioners (GPs) to link workers. Link workers consult with the patients and connect them to existing social activities and resources based on the patients’ individual needs. So far, there are no studies exploring the utilization of SP in XXX.The objective is to determine the utilization of the offered link working, including number and duration of consultations, form of delivery, no-show rate, recommended social activities and resources.Data were collected as part of a multi-centre, 2:1 randomized controlled feasibility trial aimed at patients aged 18 years or older presenting with one or more psychosocial problems at one of nine GP offices in XXX and XXX, XXX. Link working (intervention group) was tested against treatment as usual plus a brochure listing social activities and resources (control group). The utilization of link working for participants in the intervention group was analysed descriptively.In total, 234 participants (62% female, mean age 57 years, SD = 20) were recruited into the trial. 123 participants were randomized into the intervention group, out of which 114 participants (92.7%) had at least one link working consultation. Preliminary results show that participants had a median of 2 consultations (IQR 1-3, range 1-7) and only 5 participants (4.4%) had more than 5 consultations. The average consultation lasted 40 minutes. Regarding the mode of delivery, 80.4% of consultations took place in person at the GP office, 14.3% via telephone and 5.3% as home visits. Participant no-shows accounted for 18% of scheduled consultations. A broad range of social activities and resources were recommended, e.g. counselling, care and social support services, and recreational activities.The offered link working services were taken up well by the intervention group. In most cases, a maximum of five consultations were sufficient to deliver link working. Consultations were mostly delivered in person at GP offices.The results expand the understanding of link working utilization and delivery and provide practical information to plan future SP interventions and evaluations.

Social Prescribing (SP) aims to address social problems in primary care by linking medical services of General Practitioners (GPs) with social support services through a Link Worker (LW). Although existing evidence shows SP can improve wellbeing, SP has not been specifically tailored to meet the needs of people in potentially vulnerable circumstances.To adapt SP to the needs of three groups: a) lesbian, gay, bisexual, transgender, intergender, queer (LGBTIQ) persons, b) first-generation migrants and refugees, and c) older adults living alone.The co-creation process followed an adapted framework by Hawkins et al. (2017). In phase one, SP manuals and protocols were reviewed, and workshops with each target group were conducted to develop case vignettes. In phase two, these vignettes formed the basis for co-production workshops that identified adaptations to core SP components, including recruitment strategies, GP and LW training, and considerations of inclusion and equity. In phase three, Local Advisory Boards (LABs) were convened in 10 hubs, comprising representatives from all three groups and GPs. These LABs reviewed the proposed adaptations for local feasibility. Their feedback was combined with earlier findings from earlier phases to derive final to produce final recommendations, which were then refined and endorsed in a consensus conference with all hubs and stakeholder representatives.Across co-creation hubs, participants identified barriers to accessing SP. LGBTIQ participants emphasized the need for visibly safe practice environments, including respectful handling of self-identifications and pronouns. Refugees and first-generation migrants described language barriers as the central obstacle and recommended low-threshold explanations and culturally competent LWs. Older adults living alone stressed the importance of overcoming psychological and physical barriers through communication and flexible contact options. Across all groups, participants recommended sensitivity training for practice teams and LWs, and tailored approaches that strengthen trust and social participation.The co-creation process provides important insights into how SP can be tailored to the specific needs and lived realities of the target groups.The resulting adaptations offer valuable guidance not only for the three groups but also for other populations facing similar vulnerabilities. The next step is to evaluate these tailored interventions in a European randomized controlled trial.

Social determinants, inactivity, and isolation contribute to chronic disease, yet traditional healthcare often focuses solely on medical interventions. Social prescribing clinician-led referrals to non-medical community-based activities offers a novel approach to improving physical, mental, and social health. This report presents two complementary models: physician-led walking groups and structured social prescribing programs, demonstrating measurable health outcomes across diverse populations.Author 1 and Author 2 implemented programs where clinicians referred patients to community activities promoting movement, social connection, and nature exposure. One model, physician-led walking groups, provided low-impact, supervised physical activity with medical oversight. Another model, structured social prescriptions in community settings, connected patients to cycling, swimming, and other activities tailored to individual needs. Outcomes included clinical indicators (e.g., blood pressure, hemoglobin A1c), medication reduction, mental health improvement, and participant adherence.Programs showed improvements in lifestyle-related disease outcomes, mental health, and patient self-efficacy. Clinicians also reported reduced burnout. Key lessons include the importance of structured referral pathways, accessible activities, and integration of movement, nature, and social connection into clinical practice. Scalability is feasible in diverse healthcare contexts with community partnerships.These interventions illustrate practical, low-cost strategies to address chronic disease beyond pharmaceuticals. By fostering social belonging, encouraging physical activity, and exposing patients to restorative environments, primary care clinicians can deliver holistic, patient-centered care. The dual model underscores the value of clinician engagement in both direct activity leadership and referral coordination.Social prescriptions and physician-led walking programs improve health outcomes, reduce healthcare utilization, and enhance clinician well-being. They operationalize lifestyle medicine principles in real-world settings, offering scalable, evidence-based strategies for primary care worldwide.

Across Europe, general practitioners (GPs) frequently care for patients facing social vulnerability, fragmented access to care and low confidence in managing their health. Social prescribing and health mediation aim to strengthen patient empowerment—defined as an individual’s capacity to understand, manage and act on their health. The Health Empowerment Scale (HES) measures this construct, but no validated XXXX version existed, and it had not previously been tested in primary care or in social prescribing programmes.To validate the XXXX version of the Health Empowerment Scale (F-HES) and assess its feasibility for use in primary care social prescribing and health mediation programmes.We conducted a prospective study in a multidisciplinary primary care centre in an urban area with high social deprivation. Adult patients completed a questionnaire including sociodemographic items, the EPICES deprivation score, the XXXX HES (F-HES) and the General Self-Efficacy Scale (GSES). Psychometric analyses evaluated internal consistency (primary outcome: Cronbach’s alpha), content validity, construct validity and sociodemographic invariance.A total of 150 patients participated. Completion time for the F-HES was short (approximately three minutes), and items were reported as easy to understand. Internal consistency was high (Cronbach’s alpha = 0.83; 95% CI: 0.79–0.87). Content validity was excellent (S-CVI/Ave = 0.89). A moderate positive correlation with the GSES (r = 0.29, p = 0.01) supported construct validity. The scale also demonstrated good sociodemographic invariance, measuring empowerment similarly regardless of native language, deprivation level, chronic disease status or involvement in health mediation. No floor or ceiling effects were observed. Health mediators reported that the tool was simple to administer and useful for identifying unmet needs.The F-HES showed strong psychometric properties and was feasible to implement in a busy primary care setting serving socially vulnerable patients. Its brevity, clarity and stability across subgroups make it suitable for a wide range of primary care contexts.The F-HES is a valid, reliable and practical instrument for assessing patient empowerment in primary care, and can be used for both clinical evaluation and research within social prescribing and health mediation programmes.

Diabetic foot syndrome (DFS) is defined as foot disease in a patient with current or previously diagnosed diabetes mellitus (DM). DM screening and patient dispensary is well established in Slovakia, but the management of DFS prevention remains a major challenge for all specialists involved.ce-based medicine and diabetics.The Institute of Health Analyses, Ministry of Health, in cooperation with the Slovak Medical University analyse DFS in patients with DM in Slovakia.We bring practice-based reflection of SP in prevention of DFS from the communities of Bratislava III and IV districts: 1. Diet adherence: The Bratislava IV District Municipal Office provides meals for seniors in several ways depending on their health status and mobility. 2. Physical activity:  Municipal office supports physical activities for seniors in the beautiful natural environment of the district, especially Nordic walking group in Bratislava IV District and club aerobic exercise in Bratislava district III. 3. Lower limb care: Foot care - pedicure is often literally the Achilles heel of a diabetic. The goal is to prevent a diabetic's foot from becoming a diabetic foot. Communication between patients is important; they can inform each other about current pedicure options in their place of residence. 4. Adherence to treatment: A local council member J. Steklac, MD, PhD organizes lectures and workshops on disease prevention for senior in Bratislava District III and E. Kovacova director of Slovak League Against Cancer in Bratislava III District., where the patients exchange also their own experiences.Social prescribing (SP) is a person-centered approach used by healthcare workers.  SP connects people to non-clinical community activities and services to improve their health.The level of knowledge and innovation in DM management is constantly improving, but unfortunately, it may not be accessible to patients with adverse social characteristics. SP has the potential to be an effective mediator between evidence-based medicine and diabetics.